sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 24/12/2010
PIL Tritace 1.25mg, 2.5mg, 5mg,10mg tablets and Tritace Tablet Titration pack

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 26/11/2009 and displayed until 24/12/2010
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
Updated on 30/07/2008 and displayed until 26/11/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 25/09/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
Updated on 24/08/2004 and displayed until 25/09/2007
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Change to drug interactions
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 27/10/2003 and displayed until 24/08/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ramipril